Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03188822 · ClinicalTrials.gov registry record · NA
Steroid Delivery to the Frontal Sinus Opening With a Bioabsorbable Implant vs. a Bioabsorbable Nasal Dressing
A NA study, sponsored by University of Rochester.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03188822: Clinical Trial NA study, sponsored by University of Rochester.
NCT03188822 is a NA study that was terminated before completion, run by University of Rochester. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03188822, a NA study, was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to compare how two different post-surgical treatments that both deliver steroids to the frontal sinus opening affect your healing after frontal sinus surgery.
Primary Outcome
Grading by a blinded independent sinus expert as to whether the propel sinus stent frontal sinusotomy side is better, worse or the same, in terms of overall appearance after implant removal
Interventions
- DEVICE Bioabsorbable steroid releasing sinus implant
- DEVICE Bioabsorbable nasal dressing impregnated with steroid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-08-25 |
| Est. Completion | 2021-11-02 |
| Phase | NA |
Why NCT03188822 stopped before completion
NCT03188822 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Bioabsorbable steroid releasing sinus implant is the first listed.
NCT03188822 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03188822 about?
NCT03188822 is a clinical study titled "Steroid Delivery to the Frontal Sinus Opening With a Bioabsorbable Implant vs. a Bioabsorbable Nasal Dressing". The purpose of this study is to compare how two different post-surgical treatments that both deliver steroids to the frontal sinus opening affect your healing after frontal sinus surgery.
What is the current status of trial NCT03188822?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2017-08-25. Estimated completion is 2021-11-02.
What interventions are being tested in trial NCT03188822?
The interventions under investigation include: Bioabsorbable steroid releasing sinus implant (DEVICE), Bioabsorbable nasal dressing impregnated with steroid (DEVICE).
Who is sponsoring clinical trial NCT03188822?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03188822's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI